Oak Harvest Investment Services Purchases 18,017 Shares of CME Group Inc. (NASDAQ:CME)

Oak Harvest Investment Services increased its position in CME Group Inc. (NASDAQ:CMEFree Report) by 66.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,093 shares of the financial services provider’s stock after buying an additional 18,017 shares during the quarter. CME Group accounts for approximately 1.7% of Oak Harvest Investment Services’ investment portfolio, making the stock its 18th largest position. Oak Harvest Investment Services’ holdings in CME Group were worth $9,708,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in CME. Second Half Financial Partners LLC bought a new position in shares of CME Group during the fourth quarter worth about $2,737,000. Naples Global Advisors LLC boosted its stake in shares of CME Group by 5.6% in the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after purchasing an additional 110 shares during the last quarter. Sapient Capital LLC acquired a new stake in shares of CME Group during the fourth quarter worth $1,823,000. Bluefin Capital Management LLC acquired a new stake in shares of CME Group during the fourth quarter worth $2,891,000. Finally, FNY Investment Advisers LLC bought a new position in CME Group during the fourth quarter worth $1,074,000. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the sale, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. In the last quarter, insiders sold 54,290 shares of company stock valued at $11,393,700. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.5 %

Shares of CME stock traded down $1.02 on Thursday, hitting $196.06. 2,237,934 shares of the company’s stock traded hands, compared to its average volume of 2,471,441. The stock has a market capitalization of $70.59 billion, a price-to-earnings ratio of 22.30, a P/E/G ratio of 5.20 and a beta of 0.52. The company’s fifty day simple moving average is $204.17 and its 200 day simple moving average is $208.32. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. CME Group Inc. has a one year low of $180.11 and a one year high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the prior year, the company posted $2.42 EPS. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post 9.75 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date was Friday, June 7th. This represents a $4.60 annualized dividend and a yield of 2.35%. CME Group’s payout ratio is 52.33%.

Analyst Ratings Changes

Several analysts have recently commented on CME shares. JPMorgan Chase & Co. downgraded shares of CME Group from a “neutral” rating to an “underweight” rating and reduced their price objective for the stock from $206.00 to $187.00 in a research report on Friday, June 21st. Argus lifted their price target on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Morgan Stanley increased their price objective on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Barclays boosted their target price on CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research report on Thursday, April 25th. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $226.00 price target on shares of CME Group in a report on Wednesday. Three analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $215.90.

Check Out Our Latest Report on CME

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.